Your browser doesn't support javascript.
loading
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE).
Moehler, M; Heo, J; Lee, H C; Tak, W Y; Chao, Y; Paik, S W; Yim, H J; Byun, K S; Baron, A; Ungerechts, G; Jonker, D; Ruo, L; Cho, M; Kaubisch, A; Wege, H; Merle, P; Ebert, O; Habersetzer, F; Blanc, J F; Rosmorduc, Olivier; Lencioni, R; Patt, R; Leen, A M; Foerster, F; Homerin, M; Stojkowitz, N; Lusky, M; Limacher, J M; Hennequi, M; Gaspar, N; McFadden, B; De Silva, N; Shen, D; Pelusio, A; Kirn, D H; Breitbach, C J; Burke, J M.
Afiliação
  • Moehler M; First Department of Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Heo J; College of Medicine, Pusan National University and Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
  • Lee HC; Asan Medical Center, University of Ulsan College of Medicine, Ulsan, Republic ofKorea.
  • Tak WY; School of Medicine, Kyungpook National University Medical Center, Daegu, Republic of Korea.
  • Chao Y; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Paik SW; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Yim HJ; Department of Internal Medicine, Korea University Ansan Hospital, Ansan-si, Republic of Korea.
  • Byun KS; Department of Internal Medicine, Korea UniversityCollege of Medicine, Seoul, Republic of Korea.
  • Baron A; Department of Medicine, California Pacific Medical Center, San Francisco, CA, USA.
  • Ungerechts G; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Heidelberg, Germany.
  • Jonker D; The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada.
  • Ruo L; Department of Surgery, Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, Canada.
  • Cho M; Department of Internal Medicine, Pusan National University Yangsan Hospital, Busan, Republic of Korea.
  • Kaubisch A; Department of Medicine, Montefiore Medical Center, New York, NY, USA.
  • Wege H; Department of Medicine, Gastroenterology and Hepatology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Merle P; Hepatology Unit, Croix-Rousse Hospital, Lyon, France.
  • Ebert O; Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar, Technical University, Munich, Germany.
  • Habersetzer F; Pôle Hépato-Digestif, Hôpitaux Universitaires de Strasbourg, INSERM 1110, IHU de Strasbourg and Université de Strasbourg, Strasbourg, France.
  • Blanc JF; Hepato-Gastroenterology and Digestive Oncology Department, CHU Bordeaux, Bordeaux, France.
  • Rosmorduc O; Sorbonne Université, AP-HP, Hôpital Paul Brousse, Villejuif, France.
  • Lencioni R; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Patt R; Rad-MD, New York, NY, USA.
  • Leen AM; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
  • Foerster F; First Department of Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Homerin M; Medical Affairs, Transgene S.A., Illkirch-Graffenstaden, France.
  • Stojkowitz N; Clinical Operations, Transgene S.A., 400 Bd Gonthier d'Andernach, Parc d'Innovation, 67405 Illkirch-Graffenstaden, France.
  • Lusky M; Program Management, Transgene S.A., 400 Bd Gonthier d'Andernach, Parc d'Innovation, 67405 Illkirch-Graffenstaden, France.
  • Limacher JM; Medical Affairs, Transgene S.A., 400 Bd Gonthier d'Andernach, Parc d'Innovation, 67405 Illkirch-Graffenstaden, France.
  • Hennequi M; Biostatistics, Transgene S.A., 400 Bd Gonthier d'Andernach, Parc d'Innovation, 67405 Illkirch-Graffenstaden, France.
  • Gaspar N; Clinical Assays, SillaJen Inc., San Francisco, CA, USA.
  • McFadden B; Analytical Development and Quality Control, SillaJen Inc., San Francisco, CA, USA.
  • De Silva N; Clinical, SillaJen Inc., San Francisco, CA, USA.
  • Shen D; Clinical, SillaJen Inc., San Francisco, CA, USA.
  • Pelusio A; Clinical, SillaJen Inc., San Francisco, CA, USA.
  • Kirn DH; SillaJen Inc., San Francisco, CA, USA.
  • Breitbach CJ; Clinical, SillaJen Inc., San Francisco, CA, USA.
  • Burke JM; Clinical, SillaJen Inc., San Francisco, CA, USA.
Oncoimmunology ; 8(8): 1615817, 2019.
Article em En | MEDLINE | ID: mdl-31413923
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2019 Tipo de documento: Article